Anzeige

2008: 100/5 (Nov) pp. 727-954

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

39 articles
1.
Thyroid disease and haemostasis − a relationship with clinical implications?

Alessandro Squizzato1,2, Victor E. A. Gerdes2,3

1Department of Clinical Medicine, University of Insubria, Varese, Italy; 2Department of Vascular Medicine, Academic Medical Center, and 3Department of Internal Medicine, Slotervaartziekenhuis, Amsterdam, The Netherlands

Thrombosis and Haemostasis 2008 100 5: 727-728

http://dx.doi.org/10.1160/TH-08-09-0576

[Summary] [Free download]
2.
Adrenoreceptors, platelet reactivity and clopidogrel resistance

Yao-Zu Xiang1,2

1Research Center of Tianjin University of Traditional Chinese Medicine, Tianjin, China; 2Department of Haematology, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom

Thrombosis and Haemostasis 2008 100 5: 729-730

http://dx.doi.org/10.1160/TH08-09-0608

[Summary] [Free download]
3.
A radical explanation for the effect of the HPA-1b polymorphism in platelet αIIbβ3-integrin?

Alison H. Goodall

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK

Thrombosis and Haemostasis 2008 100 5: 731-732

http://dx.doi.org/10.1160/TH08-10-0646

[Summary] [Free download]
4.
Clues to early death from symptomatic pulmonary embolism in subjects presenting as outpatients

Samuel Z. Goldhaber

Thrombosis and Haemostasis 2008 100 5: 733-734

http://dx.doi.org/10.1160/TH08-10-0643

[Summary] [Free download]
5.
Thrombotic complications in thalassemic patients: Contribution of red blood cells and platelets

Boris Shenkman

Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel-Hashomer, Israel

Thrombosis and Haemostasis 2008 100 5: 735-735

http://dx.doi.org/10.1160/TH08-09-0584

[Summary] [Free download]
6.
Are we ready to start outpatient treatment for pulmonary embolism?

Guy Meyer

Université Paris Descartes, Faculté de médecine, Assistance Publique Hôpitaux de Paris, Division of Respiratory and Intensive Care, Hopital Europeen Georges Pompidou, Paris, France

Thrombosis and Haemostasis 2008 100 5: 736-737

http://dx.doi.org/10.1160/TH08-10-0651

[Summary] [Free download]
7.
Omics meets hypothesis-driven research - Partnership for innovative discoveries in vascular biology and angiogenesis

Curzio Rüegg1,2, Jean-Daniel Tissot3, Pierre Farmer2,4, Agnese Mariotti1

1Division of Experimental Oncology, Centre Pluridisciplinaire d’Oncologie, Faculty of Biology and Medicine, University of Lausanne, Epalinges, Switzerland; 2National Centre for Competence in Research (NCCR) Molecular Oncology, Epalinges, Switzerland; 3Service Régional Vaudois de Transfusion Sanguine, Lausanne, Switzerland; 4Swiss Institute of Bioinformatics, Bioinformatics Core Facility, Quartier Sorge, Bâtiment Génopode, Lausanne, Switzerland

Thrombosis and Haemostasis 2008 100 5: 738-746

http://dx.doi.org/10.1160/TH08-06-0348

[Summary] [Free download]
8.
[Add to basket]
Predictors of mortality from pulmonary embolism and their influence on clinical management

Cecilia Becattini, Giancarlo Agnelli

Internal and Cardiovascular Medicine and Stroke Unit, University of Perugia, Perugia, Italy

Thrombosis and Haemostasis 2008 100 5: 747-751

http://dx.doi.org/10.1160/TH08-06-0356

[Summary] [PDF] [Pay per view]
9.
[Add to basket]
Pro: ‘Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions’

Andrea Rubboli1, Jonathan L. Halperin2

1Division of Cardiology, Cardiac Catheterization Laboratory, Maggiore Hospital, Bologna, Italy; 2The Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA

Thrombosis and Haemostasis 2008 100 5: 752-753

http://dx.doi.org/10.1160/TH08-05-0334

[Summary] [PDF] [Pay per view]
10.
[Add to basket]
Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions' - Not for everybody

Vanessa Roldán1, Francisco Marín2

1Sº de Hematologia y Oncologia Médica, Hospital Universitario Morales Meseguer, Murcia, Spain; 2Sº de Cardiología Hospital, Universitario Virgen de la Arrixaca, Murcia, Spain

Thrombosis and Haemostasis 2008 100 5: 754-755

http://dx.doi.org/10.1160/TH08-06-0363

[Summary] [PDF] [Pay per view]
11.
Treatment of acute pulmonary embolism as outpatients or following early discharge - A systematic review

Muhammad Janjua1,2, Aaref Badshah2, Fadi Matta2, Liviu G. Danescu2, Abdo Y. Yaekoub2, Paul D. Stein2,3

1William Beaumont Hospital, Royal Oak, Michigan, USA; 2St. Joseph Mercy Oakland Hospital, Pontiac, Michigan, USA; 3Wayne State University School of Medicine, Detroit, Michigan, USA

Thrombosis and Haemostasis 2008 100 5: 756-761

http://dx.doi.org/10.1160/TH08-05-0319

[Summary] [Free download]
12.
[Add to basket]
Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia

Abdulgabar Salama, Holger Kiesewetter, Ulrich Kalus, Kamran Movassaghi, Oliver Meyer

Charité – Universitätsmedizin Berlin, Institut für Transfusionsmedizin, Berlin, Germany

Thrombosis and Haemostasis 2008 100 5: 762-765

http://dx.doi.org/10.1160/TH08-06-0418

[Summary] [PDF] [Pay per view]
13.
[Add to basket]
Modelling and expression studies of two novel mutations causing factor V deficiency

Daniel Delev1, Anna Pavlova1, Stefan Heinz2, Mathias Costa Blaise3, Tamir Chandra4, Bernd Poetsch1, Erhard Seifried2, Johannes Oldenburg1

1Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany; 2Institute for Transfusion Medicine and Immunohaematology, Red Cross Blood Donor Service, Baden-Wuerttemberg-Hessen, University Clinic Frankfurt, Germany; 3Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA; 4Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK

Thrombosis and Haemostasis 2008 100 5: 766-772

http://dx.doi.org/10.1160/TH08-02-0106

[Summary] [PDF] [Pay per view]
14.
[Add to basket]
Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort

Céline Chauleur1,5, Eva Cochery-Nouvellon1,3, Eric Mercier1,2,3, Guy Aya3,4, Pierre Marès4, Patrick Mismetti5, Géraldine Lissalde-Lavigne1,3, Jean-Christophe Gris1,2,3

1Haematology laboratory, University Hospital, Nîmes, France; 2Haematology laboratory, Faculty of Pharmaceutical and Biological Sciences, Montpellier 1 University, Montpellier, France; 3Research group EA2992, Nîmes; 4Department of Gynaecology and Obstetrics, University Hospital, Nîmes, France; 5EA3065, Saint-Etienne, France

Thrombosis and Haemostasis 2008 100 5: 773-779

http://dx.doi.org/10.1160/TH08-06-0376

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Venous thromboembolism in the elderly A community-based perspective

Frederick A. Spencer1,2, Joel M. Gore2, Darleen Lessard2, Cathy Emery2, Luigi Pacifico3, George Reed2, Jerry H. Gurwitz2, Robert J. Goldberg2

1Department of Medicine, McMaster University Medical Center, Hamilton, Ontario, Canada; 2Department of Medicine, University of Massachusetts Medical School, Worcester, Massachussetts, USA; 3Department of Medicine, Fallon Community Health Care, Worcester, Ontario, Canada

Thrombosis and Haemostasis 2008 100 5: 780-788

http://dx.doi.org/10.1160/TH08-04-0255

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
Clinical outcome of patients with major bleeding after venous thromboembolism - Findings from the RIETE Registry*

José Antonio Nieto1, Timoteo Camara1, Elena Gonzalez-Higueras1, Nuria Ruiz-Gimenez2, Ricardo Guijarro3, Pablo Javier Marchena4, Manuel Monreal5; for the RIETE Investigators*

1Servicio de Medicina Interna, Hospital Virgen de la Luz, Cuenca, Spain; 2Servicio de Medicina Interna, Hospital de la Princesa, Madrid, Spain; 3Servicio de Medicina Interna, Hospital Carlos Haya de Málaga, Spain; 4Servicio de Medicina Interna, Hospital de Sant Boi (Barcelona), Spain; 5Professor of Medicine, Servicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Thrombosis and Haemostasis 2008 100 5: 789-796

http://dx.doi.org/10.1160/TH08-06-0390

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
Major haemorrhage related to surgery in patients with type 1 and possible type 1 von Willebrand disease

Adriana Inés Woods1, Alicia Noemí Blanco2, Roberto Chuit3, Susana Sara Meschengieser2, Ana Catalina Kempfer1, Cristina Elena Farías1, María Angela Lazzari1

1Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 2Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematológicas, and 3Instituto de Investigaciones Epidemiológicas, Academia Nacional de Medicina, Buenos Aires, Argentina

Thrombosis and Haemostasis 2008 100 5: 797-802

http://dx.doi.org/10.1160/TH-07-12-0757

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
Subclinical hyperthyroidism seems not to have a significant impact on systemic anticoagulation in patients with coumarin therapy

Jan Bucerius1, Anna Naubereit1, Alexius Y. Joe1, Samer Ezziddin1, Kim Biermann1, Jörn Risse2, Holger Palmedo1, Johannes Oldenburg3, Hans-Jürgen Biersack1

1Department of Nuclear Medicine, University of Bonn, Bonn, Germany; 2Radiology and Nuclear Medicine Institute, Bad Honnef, Germany; 3Institute for Experimental Hematology and Transfusion Medicine, University of Bonn, Bonn, Germany

Thrombosis and Haemostasis 2008 100 5: 803-809

http://dx.doi.org/10.1160/TH07-12-0733

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism

Steven B. Deitelzweig1, Russ Becker2, Jay Lin3, Josh Benner2

1Ochsner Hospital, New Orleans, Louisianna, USA; 2IMS Health, Falls Church, Virginia, USA; 3sanofi-aventis, Bridgewater, New Jersey, USA

Thrombosis and Haemostasis 2008 100 5: 810-820

http://dx.doi.org/10.1160/TH08-04-0248

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Phorbol 12-myristate 13-acetate (PMA) responsive sequence in Gαq promoter during megakaryocytic differentiation - Regulation by EGR-1 and MAP kinase pathway

Gauthami Jalagadugula1, Danny N. Dhanasekaran2,4, A. Koneti Rao1,3

1Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; 2Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; 3Departments of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; 4Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania, USA

Thrombosis and Haemostasis 2008 100 5: 821-828

http://dx.doi.org/10.1160/TH08-07-0496

[Summary] [PDF] [Pay per view]
  1-20 21-39
Next page

Articles

You've 98 Article(s) in your Basket.

Thrombosis News

TH107.2

With the expiry or pending expiry of originator low-molecular-weight heparin (LMWH) patents,...

TH 107.1

T&H has a new type of article! Read the first T&H Insights article by Lutgens et al. in the...

TH 106.6

Read the important position document from the European Heart Rhythm Association [EHRA] and the...